2280 Participants Needed

Physical Activity for Health

(MoTrPAC Trial)

Recruiting at 10 trial locations
JL
CS
Overseen ByCindy Stowe
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The goal of the Molecular Transducers of Physical Activity Consortium (MoTrPAC) is to assess molecular changes that occur in response to physical activity (PA). To achieve this aim, a mechanistic randomized controlled trial (RCT) is conducted, in which adult study participants are randomized to endurance exercise (EE) training, resistance exercise (RE) training, or no exercise Control for a period of approximately 12 weeks. The overarching hypothesis is that there are discoverable molecular transducers that communicate and coordinate the effects of exercise on cells, tissues, and organs, which may initiate processes ultimately leading to the health benefits of exercise. Because this is a mechanistic trial, the main goal is not a single health-related outcome. Rather, the goal is to generate a resource leading to the generation of a map of the molecular responses to exercise that will be used by the Consortium and by the scientific community at large to generate hypotheses for future investigations of the health benefits of PA.

Will I have to stop taking my current medications?

The trial requires that participants do not have any changes in their chronic-use medications in the last 3 months and excludes those using certain medications like beta blockers, anticoagulants, and chronic oral steroids. If you're on any of these medications, you may need to stop or adjust them before participating.

What evidence supports the effectiveness of the treatment involving endurance and resistance training for cardiovascular health?

Research shows that both endurance and resistance training can improve heart health by increasing physical performance, enhancing quality of life, and reducing risk factors for heart disease. These exercises are safe and beneficial for many patients, including those with heart conditions, when tailored to individual needs and supervised by professionals.12345

Is physical activity, like resistance and endurance training, generally safe for humans?

Physical activity, including resistance and endurance training, is generally safe for most people, but there are some risks, especially for those with certain health conditions. Resistance training can cause adverse events, particularly in people with chronic health issues, and may lead to increased blood pressure in cardiac patients if not properly supervised. However, when done correctly and under medical supervision, it can be as safe as aerobic exercise and beneficial for muscle strength and cardiovascular health.678910

How does the treatment of endurance and resistance training differ from other treatments for improving cardiovascular health?

Endurance and resistance training are unique because they improve cardiovascular health by enhancing the heart's efficiency and increasing the body's ability to use oxygen, unlike other treatments that may focus solely on medication. This type of exercise also helps reduce risk factors like high blood pressure and cholesterol, offering a holistic approach to heart health.1112131415

Research Team

ME

Mike E Miller, PhD

Principal Investigator

Wake Forest University Health Sciences

Eligibility Criteria

Adults aged 18+ who can read and speak English, are willing to consent, and have a BMI between 19-35 kg/m2. Participants should be either sedentary (exercising no more than once a week) or highly active in endurance or resistance training for over a year. Those with certain chronic diseases, recent drug use that affects exercise response, or planning significant weight changes are excluded.

Inclusion Criteria

Only one member of a household can participate
Willingness to include de-identified individual-level data at low risk of re-identification in the MoTrPAC open-access database
Persons bicycling as a mode of transportation to and from work >1 day/week etc. are not considered sedentary
See 6 more

Exclusion Criteria

I have reported lung problems.
I have a bone condition that affects how my bones use minerals.
Other (clinician judgement)
See 26 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants are randomized to endurance exercise, resistance exercise, or no exercise control for approximately 12 weeks. Assessments include cardiorespiratory fitness, muscular strength, and body composition.

12 weeks
Multiple visits for assessments and biospecimen collection

Follow-up

Participants are monitored for changes in CPET VO2 Peak, isometric knee peak torque, and various blood markers.

4 weeks

Treatment Details

Interventions

  • Endurance Training
  • Restistance Training
Trial OverviewThe MoTrPAC study is testing how the body's molecules respond to different types of physical activity. Adults will do endurance training (like running), resistance training (like lifting weights), or no exercise at all for about 12 weeks while scientists observe molecular changes.
Participant Groups
5Treatment groups
Active Control
Group I: Highly Active EEActive Control1 Intervention
A comparison group of highly active EE participants are recruited and engage only in the initial round of acute exercise testing. Highly Active Endurance Exerciser (HAEE) participants are tested on a cycle ergometer.
Group II: Sedentary REActive Control1 Intervention
Participants randomized to RE first engage in a single acute exercise test of Resistance Exerciser, consistent with their random assignment.
Group III: Highly Active REActive Control1 Intervention
A comparison group of highly active RE participants are recruited and engage only in the initial round of acute exercise testing. Highly Active Resistance Exerciser (HARE) participants are tested via a bout of resistance exercise.
Group IV: Sedentary controlActive Control1 Intervention
The control group does not engage in any acute exercise testing protocol, but biospecimens are collected prior to and following a period of rest.
Group V: Sedentary EEActive Control1 Intervention
Participants randomized to EE first engage in a single acute exercise test of Endurance Exerciser (on a cycle ergometer) consistent with their random assignment.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Florida

Lead Sponsor

Trials
1,428
Recruited
987,000+

Wake Forest University Health Sciences

Lead Sponsor

Trials
1,432
Recruited
2,506,000+

Broad Institute of MIT and Harvard

Collaborator

Trials
21
Recruited
16,300+

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborator

Trials
508
Recruited
1,090,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+

Stanford University

Collaborator

Trials
2,527
Recruited
17,430,000+

Broad Institute

Collaborator

Trials
21
Recruited
16,300+

Duke University

Collaborator

Trials
2,495
Recruited
5,912,000+

Emory University

Collaborator

Trials
1,735
Recruited
2,605,000+

Icahn School of Medicine at Mount Sinai

Collaborator

Trials
933
Recruited
579,000+

Findings from Research

Engaging in both moderate endurance exercise and specific strength training programs significantly enhances physical performance and improves cardiovascular health, making them essential for managing cardiovascular risk factors and diseases.
Higher-intensity interval training is now recommended alongside traditional exercise methods, with a focus on personalized load control to optimize recovery and performance, emphasizing that increasing daily activity, such as achieving over 7500 to 10,000 steps, also contributes positively to cardiovascular health.
[Sport and exercise in prevention and therapy of cardiovascular diseases].Hacke, C., Weisser, B.[2021]
Strength training is beneficial for patients with various cardiovascular and metabolic diseases, showing improvements in muscle strength, quality of life, and mobility, especially in older individuals.
Resistance training is considered safe and can be recommended for a broad range of patients, including those with reduced left ventricular function.
[Resistance training for patients with cardiovascular diseases].Wonisch, M., Marko, C., Niebauer, J., et al.[2021]
Dynamic resistance training can be safely included in cardiac rehabilitation for selected patients, as it does not pose a higher risk than aerobic training when properly supervised and tailored to individual needs.
Low-intensity resistance training (40-60% of maximum voluntary contraction) with controlled repetitions leads to only modest increases in blood pressure, similar to moderate endurance training, making it a viable option for improving muscle strength and cardiovascular health in patients with good cardiac function.
Recommendations for resistance exercise in cardiac rehabilitation. Recommendations of the German Federation for Cardiovascular Prevention and Rehabilitation.Bjarnason-Wehrens, B., Mayer-Berger, W., Meister, ER., et al.[2019]

References

[Sport and exercise in prevention and therapy of cardiovascular diseases]. [2021]
[Resistance training for patients with cardiovascular diseases]. [2021]
Recommendations for resistance exercise in cardiac rehabilitation. Recommendations of the German Federation for Cardiovascular Prevention and Rehabilitation. [2019]
Efficacy of combined endurance-resistance training versus endurance training in patients with heart failure after percutaneous coronary intervention: A randomized controlled trial. [2022]
[Heart patient and sports]. [2008]
Exploring participants' perspectives on adverse events due to resistance training: a qualitative study. [2023]
Adverse events reported in progressive resistance strength training trials in older adults: 2 sides of a coin. [2010]
MACE in the Race: A Canadian Perspective on Major Adverse Cardiac Events (MACE) During Running. [2022]
[The stakes of force perseverance training and muscle structure training in rehabilitation. Recommendations of the German Federation for Prevention and Rehabilitation of Heart-Circulatory Diseases e.v]. [2007]
Researchers' perspectives on adverse event reporting in resistance training trials: a qualitative study. [2022]
Physical activity in the prevention of ischaemic heart disease. [2008]
12.United Statespubmed.ncbi.nlm.nih.gov
Exercise physiology and cardiovascular fitness. [2008]
[Exercise and sports: an undervalued health resource]. [2008]
14.United Statespubmed.ncbi.nlm.nih.gov
Healthy exercise. [2018]
[Influence of physical activity on human health]. [2016]